[Remote] Sr. Scientific Advisor at Clairo

United Kingdom

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Clinical Research, PharmaceuticalIndustries

Requirements

PhD in a relevant field, preferably with clinical trial experience (Master’s degree considered for exceptional candidates)
Minimum 3–5 years of experience in clinical trial technology or related industry
Proven expertise in clinical trial conduct and drug development lifecycle
Strong proficiency in scientific consulting, clinical data surveillance, and training delivery
Demonstrated ability to communicate across disciplines and present in sales environments
Comfortable learning new roles, adaptable, and a fast learner
Effective team leader and collaborator with strong interpersonal skills
Based in or able to work from the United Kingdom (hybrid)

Responsibilities

Lead scientific strategy and support for Clario’s eCOA services across pre-sales, delivery, and marketing functions
Review clinical trial protocols and respond rapidly to meet client timelines
Design data collection strategies based on best practices, literature, compliance, and patient/site preferences
Assess project complexity and provide scientific input for capability and bid defence presentations
Attend pre-sales meetings and present scientific content to prospective clients
Support project handoff from sales to client services and contribute to staff training
Participate in post-sales customer meetings and product development decisions
Present at professional forums, lead publication efforts, and design marketing research projects
Maintain expertise in regulatory guidance, scientific literature, and internal research
Facilitate discussions with external scientists and stakeholders to support client deliverables
Lead internal and external research initiatives including webinars, white papers, and consulting services

Skills

eCOA

clinical trials

scientific strategy

data collection

regulatory guidance

protocol review

clinical science

patient reported outcomes

literature review

stakeholder engagement

publication

webinars

white papers

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free